ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      6,040.53
      -0.50%
      US Tech 100
      20,818.00
      -0.50%
      Dow Jones
      44,544.66
      -0.75%
      Brent Oil
      76.385
      0.00%
      Bitcoin
      102,206.85
      -0.20%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. UK
      5. LSE

      6. Oncimmune Holdings Plc (ONC) Quote

      Oncimmune Holdings Plc

      Oncimmune Holdings Plc (ONC)

      BeiGene Ltd
      Oncolytics Biotech Inc
      10.10
      -2.35
      (-18.88%)
      Closed January 31 11:30AM
      Delayed by 15 minutes

      Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

      Premium

      Key stats and details

      Current Price
      10.10
      Bid
      9.90
      Ask
      10.20
      Volume
      1,186,806
      8.90 Day's Range 11.90
      8.90 52 Week Range 30.20
      Market Cap
      8.094M
      Previous Close
      12.45
      Open
      11.90
      Last Trade
      774
      @
      10.4
      (O)
      Last Trade Time
      Financial Volume
      124,854p
      VWAP
      10.5202
      Average Volume (3m)
      220,066
      Shares Outstanding
      80,142,147
      Dividend Yield
      -
      PE Ratio
      2.03
      Earnings Per Share (EPS)
      0.05
      Revenue
      2.11M
      Net Profit
      4.1M

      About Oncimmune Holdings Plc

      Sector
      Medical Laboratories
      Industry
      Medical Laboratories
      Website
      www.oncimmune.com
      Headquarters
      Nottingham, Gbr
      Founded
      -
      Oncimmune Holdings Plc is listed in the Medical Laboratories sector of the London Stock Exchange with ticker ONC. The last closing price for Oncimmune was 12.45p. Over the last year, Oncimmune shares have traded in a share price range of 8.90p to 30.20p.

      Oncimmune currently has 80,142,147 shares outstanding. The market capitalization of Oncimmune is £9.98 million. Oncimmune has a price to earnings ratio (PE ratio) of 2.03.

      Ask ADVFN Intelligence (AI)

      ONC Latest News

      More News

      IN BRIEF: Oncimmune shares dive; laments slow conversion of contracts

      s PLC - Leeds, England-based autoantibody profiling research services to pharmaceutical and biotechnology industry to ...

      18 hours ago
      Alliance News

      Oncimmune Holdings PLC Trading Update

      Oncimmune Holdings PLC 31 January 2025   Oncimmune Holdings plc ("Oncimmune" or the "Company")   Trading Update     Oncimmune Holdings plc (AIM: ONC.L), a leading autoantibody profiling...

      21 hours ago
      RNS Regulatory News

      Oncimmune Holdings PLC Holding(s) in Company

      Oncimmune Holdings PLC 10 December 2024   TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BYQ94H38 Issuer Name ONCIMMUNE HOLDINGS PLC UK or Non-UK Issuer UK...

      December 10 2024
      RNS Regulatory News

      Oncimmune Holdings PLC Holding(s) in Company

      Oncimmune Holdings PLC 04 December 2024     TR-1: Standard form for notification of major holdings   NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in...

      December 04 2024
      RNS Regulatory News

      Oncimmune Holdings PLC Holding(s) in Company

      Oncimmune Holdings PLC 13 November 2024     Please note that from 22 March 2021, the Standard TR-1 Form should be completed and submitted to the FCA via our Electronic Submission System (ESS...

      November 13 2024
      RNS Regulatory News

      Oncimmune Holdings PLC Holding(s) in Company

      Oncimmune Holdings PLC 13 November 2024   TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BYQ94H38 Issuer Name ONCIMMUNE HOLDINGS PLC UK or Non-UK Issuer UK...

      November 13 2024
      RNS Regulatory News

      Oncimmune Holdings PLC Holding(s) in Company

      Oncimmune Holdings PLC 12 November 2024     Please note that from 22 March 2021, the Standard TR-1 Form should be completed and submitted to the FCA via our Electronic Submission System (ESS...

      November 12 2024
      RNS Regulatory News

      Oncimmune Holdings PLC Holding(s) in Company

      Oncimmune Holdings PLC 12 November 2024   TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BYQ94H38 Issuer Name ONCIMMUNE HOLDINGS PLC UK or Non-UK Issuer UK...

      November 12 2024
      RNS Regulatory News

      Oncimmune Holdings PLC Director/PDMR Shareholding

      Oncimmune Holdings PLC 11 November 2024   For immediate release       Oncimmune Holdings plc ("Oncimmune" or the "Company") Director/PDMR Shareholding   Oncimmune Holdings plc (AIM: ONC.L), a...

      November 11 2024
      RNS Regulatory News

      Oncimmune Holdings PLC Results of General Meeting and Total Voting Rights

      Oncimmune Holdings PLC 08 November 2024   For immediate release       Oncimmune Holdings plc ("Oncimmune" or the "Company") Results of General Meeting and Total Voting Rights   Oncimmune...

      November 08 2024
      RNS Regulatory News
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-2-16.528925619812.112.98.919860112.21039167DE
      4-4.25-29.616724738714.3514.358.921805812.20896724DE
      12-4.4-30.344827586214.5168.922006614.30841219DE
      260.555.759162303669.55268.916010415.10434828DE
      52-15-59.760956175325.130.28.912015815.83205777DE
      156-144.9-93.48387096771551578.910474440.90849119DE
      260-25.4-71.549295774635.5260.58.911309183.46847742DE

      ONC - Frequently Asked Questions (FAQ)

      What is the current Oncimmune share price?
      The current share price of Oncimmune is 10.10p
      How many Oncimmune shares are in issue?
      Oncimmune has 80,142,147 shares in issue
      What is the market cap of Oncimmune?
      The market capitalisation of Oncimmune is GBP 9.98M
      What is the 1 year trading range for Oncimmune share price?
      Oncimmune has traded in the range of 8.90p to 30.20p during the past year
      What is the PE ratio of Oncimmune?
      The price to earnings ratio of Oncimmune is 2.03
      What is the cash to sales ratio of Oncimmune?
      The cash to sales ratio of Oncimmune is 3.95
      What is the reporting currency for Oncimmune?
      Oncimmune reports financial results in GBP
      What is the latest annual turnover for Oncimmune?
      The latest annual turnover of Oncimmune is GBP 2.11M
      What is the latest annual profit for Oncimmune?
      The latest annual profit of Oncimmune is GBP 4.1M
      What is the registered address of Oncimmune?
      The registered address for Oncimmune is MEDICITY - D6 BUILDING, 1 THANE ROAD, NOTTINGHAM, NG90 6BH
      What is the Oncimmune website address?
      The website address for Oncimmune is www.oncimmune.com
      Which industry sector does Oncimmune operate in?
      Oncimmune operates in the MEDICAL LABORATORIES sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      AIQAiq Limited
      4.00p
      (33.33%)
      		37.88k
      INSPInspirit Energy Holdings Plc
      0.0036p
      (28.57%)
      		1.43B
      ALKAlkemy Capital Investments Plc
      175.00p
      (27.27%)
      		176.27k
      KNBKanabo Group Plc
      1.00p
      (25.00%)
      		461.04k
      TCFTheracryf Plc
      1.125p
      (25.00%)
      		6.72M
      MET1Metals One Plc
      0.275p
      (-35.29%)
      		16.2M
      PPSProton Motor Power Systems Plc
      0.175p
      (-22.22%)
      		848.7k
      SYMESupply@me Capital Plc
      0.0025p
      (-19.35%)
      		372.49M
      CGNRConroy Gold & Natural Resources Plc
      2.15p
      (-18.87%)
      		739.53k
      ONCOncimmune Holdings Plc
      10.40p
      (-16.47%)
      		1.19M
      INSPInspirit Energy Holdings Plc
      0.0036p
      (28.57%)
      		1.43B
      NTVONativo Resources Plc
      0.0018p
      (-5.26%)
      		1.41B
      MSMNMosman Oil And Gas Limited
      0.041p
      (10.81%)
      		1.22B
      TRPTower Resources Plc
      0.0295p
      (0.00%)
      		691.76M
      SYMESupply@me Capital Plc
      0.0025p
      (-19.35%)
      		372.49M

      Discussion

      View Full Feed
      blackhawks blackhawks 5 minutes ago
      15 years? You're showing uncharacteristic kindness. Try 'since the Clinton Admin.'
      newmedman newmedman 5 minutes ago
      I don't remember saying anything like that but it sounds like something I would have said at the time.

      You can't just block a new administration on a hunch. We'd still be in the same boat as we are today except for the fact that if Biden would have tried some thing like that, it would
      EarningsCentral EarningsCentral 6 minutes ago
      XOM
      S-BEES-BUMBLEBEE S-BEES-BUMBLEBEE 6 minutes ago
      $TANH >>> PPS-EXPLOSION IMMINENT IMO.

      WATCH OUT FOR BIG BUYS NEXT WEEK! :-D $$$$$$$$

      https://charts.stocktwits-cdn.com/production/original_602420568.jpg
      TANH
      WinstonCup WinstonCup 6 minutes ago
      Yep, looks like the dynamic duo are gone. WDLF will be in quads next week, then delisted.
      imo
      WDLF
      aBeezlee aBeezlee 7 minutes ago
      A lot of news lately that's positive, yet no real impact on price. It's not in the teens, but still very close to it. Maybe firstnet will push things up.
      ASTS
      S-BEES-BUMBLEBEE S-BEES-BUMBLEBEE 7 minutes ago
      $TANH >>> PPS-EXPLOSION IMMINENT IMO.

      WATCH OUT FOR BIG BUYS NEXT WEEK! :-D $$$$$$$$

      https://charts.stocktwits-cdn.com/production/original_602420568.jpg
      TANH
      BeachBum BeachBum 10 minutes ago
      According to a few here, it’s perfectly fine. I differ in opinion.
      AHRO
      aBeezlee aBeezlee 10 minutes ago
      Yes, it's something to be mindful of with any conpany. How efficient one is with balancing debt, dilution and wasteful spending. Considering deepseek has more attention, Verses' marketing can't be that great.
      VRSSF
      Zorax Zorax 10 minutes ago
      You would think so, but I think the brownshirts have already went into agencies and walked people out of their office in the last week. More than two heads of departments were physically removed.

      And now my Tim Horton coffee is going to be about 8 bucks American if I'm lucky. The medi
      unlimitedgains4 unlimitedgains4 11 minutes ago
      I signed up and got early access haven't funded yet but looks really good and super user friendly 
      HMBL
      Waalrus Waalrus 12 minutes ago
      Wouldn't the call still be construed as insider trading? Disclosing info to a public person that is not available to others? Asking a friend.
      AHRO
      stervc stervc 13 minutes ago
      zino, I agree... Excellent Read...

      Thanks for sharing this link as it is an excellent read for all GCAN shareholders:
      https://quantumzeitgeist.com/israel-quantum-computing-era/

      v/r
      Sterling
      GCAN
      XMaster2023 XMaster2023 13 minutes ago
      The Market Makers have more skeletons in the closet than there are in Arlington cemetery. They will not even want one deposition. All LP needs to do is stay the course. She has had plenty of opportunities to settle and passed them all up to get the MTD partially denied!
      NWBO
      Jay_B Jay_B 14 minutes ago
      What a bunch of f'n scammers these guys turned out to be.
      RWGI
      HyGro HyGro 14 minutes ago
      Sorry, JAMA gets the manuscript. They don't research all the background history. That's the reason that their are so many negative comments and publications challenging the trial and the findings. They were after JAMA review.
      NWBO
      Lime Time Lime Time 15 minutes ago
      Wow. Huge TDS on this relational database in the last 20 days. It's beyond describable. Very disturbing. Really entertaining. 🤣 😂 😆

      Uneducated Heads exploding.
      HyGro HyGro 15 minutes ago
      Sorry, JAMA gets the manuscript. They don't research all the background history. That's the reason that their are so many negative comments and publications challenging the trial and the findings. They were after JAMA review.
      NWBO
      glenngroove glenngroove 16 minutes ago
      Go Mo!
      LICH
      Oleblue Oleblue 16 minutes ago
      Palantir CEO Alex Karp discusses his book The Technological Republic and America’s new moment

      https://youtu.be/j0Oz4P-NX84

      https://api.wsj.net/api/kaavio/charts/big.chart?nosettings=1&symb=pltr&uf=32&type=4&size=4&sid=206708234&style=330&freq=1&entitlementtoken=0c333783
      PLTR
      unlimitedgains4 unlimitedgains4 17 minutes ago
      Very well wrote out. There is something bigger forsure happening here behind the scenes we just got to enjoy the ride until it comes 💯🤝
      HMBL
      QuantumMaestro53 QuantumMaestro53 18 minutes ago
      To see all of the court cases and judgements, just go here and type in Kevin Lamb or Innovative Outcomes, if the link doesn't work google Arkansas CourtConnect:

      https://caseinfonew.arcourts.gov/opad
      UBQU

      Your Recent History

      LSE
      ONC
      Oncimmune
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads